Suppr超能文献

血管化复合组织异体移植:肌肉骨骼再生的新概念。

Vascularized composite allotransplantation: a new concept in musculoskeletal regeneration.

作者信息

Siemionow Maria

机构信息

University of Illinois at Chicago, 900 South Ashland, MC 944, Chicago, IL, 60640, USA.

出版信息

J Mater Sci Mater Med. 2015 Dec;26(12):266. doi: 10.1007/s10856-015-5601-5. Epub 2015 Oct 27.

Abstract

Over the past 20 years, the fields of biomaterial sciences and tissue engineering have evolved into new clinically relevant applications including regenerative medicine and cell based therapies. Tissue engineering therapies are based on different types of materials and scaffolds combined with cells and submitted to engineering processes in order to create bio-scaffolds which will improve or replace biological functions. Despite the effort, only a few therapies, such as bone, cartilage and nerve, succeeded in clinical applications. Furthermore, the major drawback in standard application of these therapies was the critical size defects which could be covered with engineered materials, as well as inability to provide sustainable vascular supply to the created bio-scaffolds. In 1998, the first successful hand transplantation was performed in France, and the field of vascularized composite allotransplantation (VCA) was introduced into the armamentarium of reconstructive surgery (Dubernard in Am J Transplant 5(6):1580-1, 2005; Petruzzo et al. in Am J Transplant 6(7):1718-24, 2006; Lanzetta et al. in Transplantation 79(9):1210-4, 2005). As a result, a new generation of transplants including hand, face, larynx abdominal wall, lower extremities and penile transplantation became available to patients who had lost these unique organs and were previously unable to achieve restored function using standard reconstructive procedures. Ethical debate on the need for life-long immunosuppressive therapy to prevent rejection of the VCA overshadowed the success of face and hand transplants. Thus, a new, challenging opportunity developed to combine approaches of tissue engineering and regenerative medicine and ultimately restore the framework, function, aesthetics and survival of the VSA transplants. This overview presents the unique opportunities of merging established and new technologies into the burgeoning field of reconstructive transplantation.

摘要

在过去20年里,生物材料科学和组织工程领域已发展出包括再生医学和基于细胞的疗法等新的临床相关应用。组织工程疗法基于不同类型的材料和支架,结合细胞并经过工程处理,以创建能改善或替代生物功能的生物支架。尽管付出了努力,但只有少数疗法,如骨、软骨和神经疗法,在临床应用中取得了成功。此外,这些疗法标准应用中的主要缺点是工程材料所能覆盖的临界尺寸缺损,以及无法为所创建的生物支架提供可持续的血管供应。1998年,法国进行了首例成功的手部移植手术,血管化复合组织异体移植(VCA)领域被引入到重建外科的技术库中(迪贝纳尔,《美国移植杂志》5(6):1580 - 1,2005年;佩特鲁佐等人,《美国移植杂志》6(7):1718 - 24,2006年;兰泽塔等人,《移植》79(9):1210 - 4,2005年)。结果,包括手部、面部、喉部、腹壁、下肢和阴茎移植在内的新一代移植手术可供那些失去这些独特器官且先前无法通过标准重建手术恢复功能的患者使用。关于终身免疫抑制疗法以防止VCA排斥的伦理辩论给面部和手部移植的成功蒙上了阴影。因此,一个新的、具有挑战性的机会出现了,即将组织工程和再生医学方法结合起来,最终恢复VSA移植的结构、功能、美观度和存活率。本综述介绍了将现有技术和新技术融合到重建移植这个新兴领域的独特机会。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验